Neogen (NEOG) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -21.20% |
| Nov 30, 2025 | -19.79% |
| Aug 31, 2025 | 2.53% |
| May 31, 2025 | -83.49% |
| Feb 28, 2025 | -19.30% |
| Nov 30, 2024 | -74.11% |
| Aug 31, 2024 | -19.42% |
| May 31, 2024 | -15.60% |
| Feb 29, 2024 | -15.33% |
| Nov 30, 2023 | -15.60% |
| Aug 31, 2023 | -49.01% |
| May 31, 2023 | -34.82% |
| Feb 28, 2023 | -34.02% |
| Nov 30, 2022 | -20.83% |
| Aug 31, 2022 | -26.30% |
| May 31, 2022 | -10.95% |
| Feb 28, 2022 | -24.21% |
| Nov 30, 2021 | -14.59% |
| Aug 31, 2021 | -4.36% |
| May 31, 2021 | -11.09% |
| Feb 28, 2021 | -9.99% |
| Nov 30, 2020 | -8.97% |
| Aug 31, 2020 | -9.71% |
| May 31, 2020 | -10.42% |
| Feb 29, 2020 | -9.71% |
| Nov 30, 2019 | -6.51% |
| Aug 31, 2019 | -10.22% |
| May 31, 2019 | 9.16% |
| Feb 28, 2019 | 6.79% |
| Nov 30, 2018 | 12.77% |
| Aug 31, 2018 | 5.68% |
| May 31, 2018 | 12.34% |
| Feb 28, 2018 | 10.99% |
| Nov 30, 2017 | 11.67% |
| Aug 31, 2017 | 3.90% |
| May 31, 2017 | -0.78% |
| Feb 28, 2017 | -1.89% |
| Nov 30, 2016 | 0.00% |
| Aug 31, 2016 | -5.11% |
| May 31, 2016 | 0.76% |
| Feb 29, 2016 | 0.93% |
| Nov 30, 2015 | -2.33% |
| Aug 31, 2015 | -0.78% |